The aim of the work is to analyze the data of patients with malignant neoplasms of the breast and lungs, to investigate the structure of dental complications before and after chemotherapy, to determine the effectiveness of dental prophylaxis.
 Materials and methods. 60 cancer patients both men and women were examined, who received chemotherapy at the ONCOLIFE Medical Center (Zaporizhzhia). All respondents were divided into groups by cancer: the first group consisted of 30 patients with lung cancer, the second one 30 patients with breast cancer, and the third (control) group contained 30 people who do not suffer from cancer. The research results are processed by modern statistical methods of analysis on a personal computer using the software package Statistica 13.
 Results. It was found that before chemotherapy, dental complications had 70% of patients with lung cancer, 66.7% of patients with breast cancer, 70% of people without cancer, ie there was no statistically significant difference between groups (p> 0.05). In all groups, the results of prevention determined improvement, which was statistically significant by the Wilcoxon test. Although the difference between the groups was statistically significant according to the Kraskel-Wallis test (p <0.05) and there was a statistically significant difference between patients with lung cancer and breast cancer according to the Mann-Whitney test, but the indicators in the group with breast cancer and group without cancer (p> 0.05), which indicates the effectiveness of dental prophylaxis.
 Conclusions. Cancer patients receiving antitumor chemotherapy are at risk for certain dental complications, such as mucositis, xerostomia, dygeusia. 13.33% of patients with lung cancer and 16.67% of patients with breast cancer in the study had acute mucositis. Patients with poor oral health, poor oral hygiene, caries and its complications, and incorrect orthopedic structures are more likely to experience dental complications during chemotherapy. The OHI-S hygiene index before prophylaxis was 1.75 (1.40; 2.20) in patients with lung cancer; 1.40 (1.30; 1.80) in patients with breast cancer. The GI gingivitis index before prophylaxis was 1.55 (1.10; 1.90) in patients with lung cancer; 1.25 (1.10; 1.60) in patients with breast cancer. The PMA index before prophylaxis was 62.0 (45.0; 77.0) in patients with lung cancer; 53.0 (43.0; 60.0) in patients with breast cancer.
Read full abstract